Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis

Explore clinical trials studying Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis trial results

Recruiting

Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age

NCT07207408

Conditions: Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis
Locations: 103 Miami, Florida, United States

AMR- El Dorado El Dorado, Kansas, United States

AMR- Las Vegas Las Vegas, Nevada, United States

CTI Clinical Research Center Cincinnati, Ohio, United States

View Trial Details